Repligen | RGEN - Fremdkapital





Fremdkapital Veränderung Datum
Agilent USD 3.05B 1000K 2026-03
Align Technology USD 0 0 2024-12
Bio Techne USD 200M 60M 2026-03
BioMarin Pharmaceutical USD 1.43B 833.11M 2026-03
Bristol-Myers Squibb USD 42.15B 698M 2026-03
Bruker USD 1.66B 189.6M 2026-03
Charles River Laboratories USD 2.66B 526.77M 2026-03
Danaher USD 25.15B 7.59B 2026-06
Dentsply International USD 2.01B 9M 2026-03
General Electric Aerospace USD 17.16B 1.02B 2026-06
Henry Schein USD 2.33B 17M 2026-03
Illumina USD 1.49B 0 2026-03
IQVIA Holdings USD 13.7B 284M 2026-06
Mettler Toledo International USD 2.16B 73.35M 2026-03
Myriad Genetics USD 120.3M 400K 2026-03
OraSure Technologies USD 100K 17K 2025-12
Pacific Biosciences Of California USD 645.38M 223K 2025-12
Pfizer USD 60.57B 1.08B 2026-03
Repligen USD 551.05M 4.46M 2026-06
Revvity USD 2.63B 836K 2026-03
Standard Biotools USD 299K 0 2026-03
Thermo Fisher Scientific USD 39.18B 890M 2026-06
Waters USD 5.22B 3.81B 2026-03
West Pharmaceutical Services USD 202.9M 100K 2026-06